Ipsen receives CRL for potential bone treatment 05-Jan-2023 By Ben Hargreaves The drug candidate palovarotene is knocked back by the FDA, as the agency requests additional information on clinical trial data.
Hospira initiates recall after glass found in antibiotic vials 04-Jan-2023 By Ben Hargreaves The subsidiary of Pfizer voluntarily recalled a lot of vancomycin hydrochloride injection after an inspection found glass particulates in a vial.
Hovione and GEA aim to increase adoption of continuous tableting 04-Jan-2023 By Ben Hargreaves The two companies, who had previously established a customer-supplier relationship, have created an agreement to advance the technology and to encourage adoption.
Fujifilm invests in PhenoVista to support development of drug discovery services 03-Jan-2023 By Nick Taylor Fujifilm has invested in PhenoVista Biosciences through its venture capital arm to support development of high-content screening (HCS) assay services.
Phlow and US Pharmacopeia open labs for API R&D services 03-Jan-2023 By Ben Hargreaves The partners announce that their lab facilities have opened, equipped with advanced manufacturing technologies to create API and KSMs.
Cabinet Health raises $17m for sustainable packaging 03-Jan-2023 By Ben Hargreaves The company aims to reduce the single-use plastics utilized in packaging across the pharma industry and has received funding to expand its business.